Skip to main content
. 2012 Jul 1;2012:436046. doi: 10.5402/2012/436046

Table 2.

Alport syndrome disease progression in this trial.

Progression Definition
Stage 0 to I Albuminuria >30 mg albumin/gCrea in combination with a 3-fold increase from baseline in albuminuria, confirmed within 2 weeks.
Stage I to II (i) Twofold increase from baseline albuminuria, confirmed within 2 weeks
(ii) Albuminuria >300 mg albumin/gCrea at a single assessment.